These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27023129)

  • 21. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
    Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
    J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation, LC-MS/MS and 2D-NMR characterization of alkaline degradants of tenofovir disoproxil fumarate.
    Anandgaonkar V; Gupta A; Kona S; Talluri MV
    J Pharm Biomed Anal; 2015 Mar; 107():175-85. PubMed ID: 25594895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LC, LC-MS/TOF and MS(n) studies for the identification and characterization of degradation products of nelfinavir mesylate.
    Tiwari RN; Bonde CG
    J Pharm Biomed Anal; 2011 Jun; 55(3):435-45. PubMed ID: 21392920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural characterization of low level degradants in aztreonam injection and an innovative approach to aid HPLC method validation.
    Ye Q; Ding W; Rinaldi F; Huang Y; Miller SA; Bolgar M
    J Pharm Biomed Anal; 2016 May; 124():358-364. PubMed ID: 26991056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method.
    Bansal G; Singh R; Saini B; Bansal Y
    J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a stability indicating assay of doxofylline by RP-HPLC: ESI-MS/MS, ¹H and ¹³C NMR spectroscopic characterization of degradation products and process related impurities.
    Rao RN; Naidu ChG; Prasad KG; Santhakumar B; Saida S
    J Pharm Biomed Anal; 2013 May; 78-79():92-9. PubMed ID: 23466440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and structural elucidation of two process impurities and stress degradants in darifenacin hydrobromide active pharmaceutical ingredient by LC-ESI/MS(n).
    Thomas S; Paul SK; Shandilya S; Agarwal A; Saxena N; Awasthi AK; Matta Hb; Vir D; Mathela CS
    Analyst; 2012 Aug; 137(15):3571-82. PubMed ID: 22733388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
    Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
    J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and structural characterization of degradation products of afatinib dimaleate by LC-Q-TOF/MS/MS and NMR: cytotoxicity evaluation of afatinib and isolated degradation products.
    Chavan BB; Sawant V; Borkar RM; Ragampeta S; Talluri MVNK
    J Pharm Biomed Anal; 2019 Mar; 166():139-146. PubMed ID: 30640044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural characterization of a novel degradant of the antifungal agent posaconazole.
    Zhong W; Yang X; Tong W; Martin GE
    J Pharm Biomed Anal; 2012 Jul; 66():40-9. PubMed ID: 22464557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gradient RP-HPLC method for the determination of potential impurities in atazanavir sulfate.
    Chitturi SR; Somannavar YS; Peruri BG; Nallapati S; Sharma HK; Budidet SR; Handa VK; Vurimindi HB
    J Pharm Biomed Anal; 2011 Apr; 55(1):31-47. PubMed ID: 21316175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural identification of degradants of moexipril by LC-MS/MS.
    Challa PR; K R; K M V NR
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28493358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study on the forced degradation behaviour of ledipasvir: Identification of major degradation products using LC-QTOF-MS/MS and NMR.
    Swain D; Samanthula G
    J Pharm Biomed Anal; 2017 May; 138():29-42. PubMed ID: 28171790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and structural characterization of hydrolytic degradation products of alvimopan by LC/QTOF/MS/MS and NMR studies.
    Baira SM; R S; Talluri MVNK
    J Pharm Biomed Anal; 2019 Feb; 165():399-409. PubMed ID: 30590338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid structure elucidation of drug degradation products using mechanism-based stress studies in conjunction with LC-MS(n) and NMR spectroscopy: identification of a photodegradation product of betamethasone dipropionate.
    Lin M; Li M; Buevich AV; Osterman R; Rustum AM
    J Pharm Biomed Anal; 2009 Oct; 50(3):275-80. PubMed ID: 19525081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of degradation products of midazolam maleate by UHPLC-HR-IT-MS
    Feng X; Du G; Hou T; Liu X; Chao R
    Pharmazie; 2017 Feb; 72(2):73-80. PubMed ID: 29441856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RP-HPLC separation and ESI-MS, 1H, and 13C NMR characterization of forced degradants including process related impurities of carisbamate: method development and validation.
    Rao RN; Ramakrishna K; Sravan B; Santhakumar K
    J Pharm Biomed Anal; 2013 Apr; 77():49-54. PubMed ID: 23376724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.